The Mexican Consortium of Epidemiological Studies for the Prevention, Diagnosis, and Treatment of Chronic Kidney Disease: a review of collaborating studies.
Salud Publica Mex
; 64(4, jul-ago): 434-442, 2022 Jun 29.
Article
em En
| MEDLINE
| ID: mdl-36130388
ABSTRACT
OBJECTIVE:
To harmonize participants' information from five epidemiological studies. MATERIALS ANDMETHODS:
The Mexican Consortium of Epidemiological Studies for the Prevention, Diagnosis, and Treatment of Chronic Kidney Disease (RenMex, by its Spanish acronym) was established in 2018. RenMex is a consortium of five studies The Mexican Teachers Cohort Study; the Mexico City Diabetes Study; the Health Workers Cohort Study; the Comitán Study; and the Salt Consumption in Mexico Study, which assessed baseline serum creatinine, albumin, and C-reactive protein, all performed with standardized techniques.RESULTS:
RenMex includes 3 133 participants, with a mean age of 44.8 years, 68.8% women, 10.8% with a previous medical diagnosis of type 2 diabetes, and 24.1% living with obesity.CONCLUSIONS:
In the future, RenMex will work on more detailed analyses with each cohort allowed to opt in or out for each topic according to their individual data.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Diabetes Mellitus Tipo 2
/
Insuficiência Renal Crônica
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Male
País/Região como assunto:
Mexico
Idioma:
En
Revista:
Salud Publica Mex
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
México